Search

Search Constraints

You searched for: Author/Creator Chen, Chi‐Yi

Search Results

1. A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B. (11th November 2022)

2. A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. Issue 11 (10th October 2022)

3. Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan. Issue 11 (25th October 2018)

4. Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis. Issue 5 (18th July 2022)

5. Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan. (12th March 2021)

6. Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. (4th October 2016)

7. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort). Issue 10 (21st May 2021)

8. Higher adherence with 3‐year entecavir treatment than lamivudine or telbivudine in treatment‐naïve Taiwanese patients with chronic hepatitis B. Issue 1 (January 2014)

10. Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second‐Line Treatment of Helicobacter pylori: A Randomized Trial. (March 2016)